Objective: To describe the development and implementation of General Psychiatric Management (GPM), a dynamically informed psychotherapeutic and case management approach along with symptom-targeted pharmacological interventions for the treatment of borderline personality disorder (BPD), derived from the American Psychiatric Association's (APA) guidelines for treating BPD.
B PD is a common disorder found in about 2% of the general population, 10% of psychiatric outpatients, and 20% of psychiatric inpatients. 1 Patients with BPD are frequent users of mental health services during their lifetime 2 and represent an increased risk for death by suicide. According to findings from Zanarini and colleagues, 3 95% of people with BPD will receive individual therapy, 72% will require a psychiatric hospitalization, 40% will be taking 3 or more psychotropic medications concurrently, 20% will be prescribed 4 or more medications, and 10% will require more than 5 medications. Although the efficacy of 4 psychosocial interventions has been demonstrated in RCTs, [4] [5] [6] the effectiveness of these interventions, including DBT, in real-world settings has not yet been substantiated. 7 In 2001, the APA developed their Practice Guideline for the Treatment of Patients with Borderline Personality Disorder, 8 which represented a comprehensive set of best practice recommendations for the psychiatric community. This guideline was felt to reflect high-standard yet typical outpatient care provided by a multidisciplinary team associated with a general hospital psychiatric program and therefore represented an appropriate comparison for an effectiveness trial. We implemented an RCT to evaluate the clinical and cost-effectiveness of DBT for patients with BPD in comparison with experienced clinicians using a therapy derived from the APA guideline. Christensen et al 9 noted that a dominant factor associated with effectiveness research is conducting the trial in a real-world setting. The purpose of our report was to describe the development of the APA's guideline in an outpatient general hospital setting and to determine whether clinicians could demonstrate adherence to the recommendations. We defined adherence according to the definition by Waltz et al 10 as the degree to which therapists employ interventions stipulated by treatment manuals and simultaneously avoid those that are prohibited. Specifically, our investigation reports on the therapists' adherence to GPM as measured by the GPMAS and outlines the initial findings regarding the reliability and validity of the GPMAS.
General Psychiatric Management
The therapy developed from the APA's guideline was called GPM. We wanted GPM to be applicable to well-resourced outpatient psychiatric teams where many patients with BPD are typically followed. Our RCT involved 2 sites: an urban general hospital setting chosen to implement the APA's guideline and a large addiction and mental health hospital where the DBT arm was conducted. This section briefly describes the underlying principles and the 3 components of GPM: case management, dynamically informed psychotherapy, and symptom-targeted medication management. GPM was derived from the care promoted in the APA's guideline, which advocates for the use of psychotherapy as the primary treatment modality for BPD in concert with symptomtargeted pharmacological interventions. To avoid contamination with the DBT comparison arm, the GPM psychotherapy component in our study was based on a psychotherapeutic-psychodynamic approach drawn from the writings of Gunderson. 11 Several overarching principles of GPM for managing patients with BPD were identified: patients were viewed as competent adults who were expected to be active participants in all aspects and phases of treatment; therapists were encouraged to be flexible, within reason, regarding patients' preferences for the focus of the therapy; and significant attention was accorded to improving patients' role functioning. 12 The case management activities and interventions for GPM were derived from the APA's guideline, which included responding to crises, safety monitoring, establishing and monitoring a therapeutic framework and alliance, educating patients and their families about the disorder, facilitating adherence to the treatment regimen, coordinating multimodal therapies, and monitoring clinical status and treatment plans.
The psychotherapy component emphasized the relational aspects of the disorder and attributed difficulties to a deficit model focusing on the consequences of precarious early attachment relationships. 11 Although Gunderson formulated intolerance of aloneness as the core dynamic of BPD, we targeted our therapy to exploring the consequences of disturbed attachment relationships on patients' emotional processing. With the focus of therapy on emotional processing difficulties, we adapted strategies targeting emotional processing to be included in GPM. 13 As formulated, GPM had areas of overlap with DBT (for example, validation, supervision of therapist, and attention to emotions) but was distinctly different by not incorporating elements such as mindfulness, reviewing diaries or thought cards, phone coaching, skills training, behavioural chain analysis, extinction, role playing, Medication management was based on the symptom-targeted approach presented in the APA's guideline. As patients were selected for having parasuicidal behaviour and the primary outcome for the RCT was prevention of these behaviours, 2 algorithms-one related to mood lability and the other to impulsivity-aggressiveness-were prioritized as symptomtargets for pharmacotherapy. However, as GPM encouraged flexibility and attention to patients' preferences, therapists were allowed to deviate from strict adherence to the algorithms.
The following policies guided the implementation of GPM:
Ancillary Treatments
GPM encouraged multiple treatment modalities for each patient on an individual basis. For example, one patient was given resources for group therapy to deal with previous sexual trauma, another patient had separate case management by a therapist external to the study but knowledgeable of the protocol, and a different patient joined a psychoeducational group. Ancillary treatments were dictated by the individual needs of the patient and conformed to the widely held view that psychotherapy with suicidal people take a multimodal and community approach. 14 This principle is also consistent with the recommendation 11 that treatment of patients with BPD involves more than one care provider and (or) therapeutic modality. For the purpose of the study, patients were discouraged from participating in cognitive-behavioural therapy programs, including any treatments involving formal skills training that could lead to contamination of GPM interventions.
Telephone Policy
Therapists were not available after working hours, and we instructed patients to use the psychiatric emergency service at our hospital site as emergency service personnel were well-informed about our protocol. For patients not living close to our service, we encouraged them to seek crisis support from their closest hospital's emergency department. Depending on therapists' personal approach to managing patients in individual psychotherapy, patients were offered intersession telephone contact based on their need.
Supervision Group
GPM involvement necessitated a commitment to attend our weekly 90-minute peer supervision group. The supervision group had 4 purposes: 1) to anchor therapists to the GPM approach, including individual feedback on adherence; 2) to problem solve around clinical dilemmas using input from multiple perspectives; 3) to create a safe venue for discussing countertransference issues; and 4) to attend to administrative issues related to the study operations. Physician therapists were able to credit their time in supervision as contributing to their continuing professional development requirements.
GPM Monitoring
Questions related to maintaining GPM integrity were discussed regularly in peer supervision. One of the authors and developers of GPM facilitated the supervisory sessions and provided the therapists with weekly guidance and feedback about their adherence to the protocol. In addition, therapists received empirical data on an annual basis about their adherence to GPM elements. The feedback was based on a summary of the ratings of the self-report GPMAS (discussed below) prepared by a research assistant. Particular attention was given to therapists using prohibited therapy elements; when indicated, therapists were encouraged to remain on target regarding GPM therapeutic elements. Each year of the trial, the GPM therapists had an external consultation with an internationally recognized expert in the psychiatric care of BPD patients (Dr John Gunderson, Dr John Oldham, and Dr Ken Silk).
Method

Subjects
Ethics approval for this adherence study was obtained from St Michael's Hospital Research Ethics Board. Participants were male and female outpatients, aged between 18 and 60 years, on existing hospital wait-lists for treatment of BPD who met Diagnostic and Statistical Manual of Mental Disorders, fourth edition, criteria for this condition according to the IPDE. The IPDE is a widely established personality measure used by the World Health Organization. 15 Subjects must have had at least 2 parasuicide attempts in the past 5 years, with one attempt occurring in the 3 months prior to enrolling in the study. Exclusion criteria included the presence of certain other psychiatric disorders (substance dependence, dementia, and psychotic or bipolar I disorder) and current participation in DBT or GPM treatment. All eligible participants provided written informed consent after the research procedures had been explained to them. Participants (n = 180) meeting these criteria were randomly assigned to 1 of 2 treatment conditions: DBT treatment or GPM. Among the entire sample, the first 50 subjects randomized to the GPM arm participated in the current study. Among these people, 84.4% were women and 15.6% were married. The average age was 31.7 years, SD 10.6 years.
Assessments
Developed by the GPM clinicians, the GPMAS is a 49-item scale based on principles of GPM that taps general therapist interventions and behaviours relevant to the treatment of patients with BPD, including delivery of dynamically 16 that requires raters to select from a continuum of 5 options, ranging from no emphasis to major emphasis.
Several steps were taken to assess the therapists' adherence to GPM. In developing the manual for GPM and the GPMAS, the therapists identified the essential treatment elements as the following: encouraging concurrent treatments; encouraging multimodal treatment; demonstrating flexibility; attending to the role of patient preference regarding the focus of the psychotherapy; demonstrating empathy and validation; affirming positive transference; being active with negative transference when it arises; focusing on identification of feelings; clarifying maladaptive responses to feelings; connecting behaviours to events, thoughts, and feelings; inquiring about what the patient has learned in therapy; and expanding the focus of the therapy away from self-harm. Therapists in the DBT arm created a list of interventions drawn from DBT that would be prohibited in GPM. The GPM therapists were also asked to score the amount of emphasis placed on proibited items using the same rating scale. Prohibited items (8 in total) included such interventions as phone coaching, using mindfulness, and conducting skills training. These items were embedded within the GPMAS to make them less conspicuous when scored by the clinician-raters. Therapists were also required to list all prescription medications that their patients were taking at the time of each session on a supplementary sheet attached to the GPMAS.
Therapists were asked to complete the GPMAS every 6 weeks for each patient they saw in weekly therapy sessions during 1 year. They were instructed to confine their responses to what had transpired during the past session, as opposed to providing a global evaluation for the previous weeks, to avoid carryover effects of one particular session affecting all intervening sessions. This report is based on data from the first 50 patients participating in GPM. To assess the test-retest reliability of the GPMAS, 25 therapy sessions comprising a convenience sample and drawn from multiple combinations of patients, therapists, and phases of treatment were analyzed. Therapists were requested to complete the GPMAS following the sampled session and then immediately return the survey to a research assistant. They were then presented with a second GPMAS about 1 week later and were asked to fill out the survey based on their recollection of what had taken place during the same therapy session. Therapists had access to their notes from the index session. Comparing therapists' ratings to ratings supplied by the patients for the same therapy session tested a measure of concurrent validity. After providing the appropriate consent, study subjects were invited to complete a survey asking them to rate, from their own perspectives, the amount of emphasis devoted to various treatment interventions during the previous therapy session. When designing the abbreviated GPM patient questionnaire, selected items (18 in total) drawn from the GPMAS and the prohibited list of DBT interventions were translated into language equivalent to a sixth-grade reading level by one of the study investigators. Translated items were proof-read by 2 PhD research psychologists who offered feedback and suggestions for revision. The abbreviated GPM patient questionnaire was structured similarly to the GPMAS and used the same rating system to gauge the amount of emphasis placed on various interventions by the treating therapist. Patient participants were asked to complete their surveys in private on finishing the therapy session. Abbreviated GPM patient questionnaires (n = 26) were collected from the sample of therapy sessions representing different combinations of patients and clinicians.
Analyses
Data from the GPMAS surveys and patient questionnaires were numerically coded and analyzed using SPSS software, version 12.0 (SPSS Inc, Chicago, IL). Therapy sessions were divided into categories based on when they had taken place during the course of treatment and then analyzed together as a group. Sessions corresponding to the early phase of treatment were those that occurred on either the initial assessment or week 6; sessions corresponding to the middle phase of treatment were those that took place between weeks 7 and 36; and sessions corresponding to the late phase of treatment were those from week 37 onward to the termination of therapy. Changes in emphasis of interventions over time were considered. Comparisons between groups and phases of treatment were achieved using chi-square tests and ANOVA. Bonferroni post hoc analyses were used to correct for multiple comparisons. Cronbach alpha coefficients were used to assess the internal consistency reliability of the GPMAS subscales. Tabachnik and Fidell 17 recommended that alpha coefficients fall between 0.7 and 0.9. The ICC was calculated using a 2-way random model to determine the test-retest reliability and the convergence between subject and therapist self-report. As proposed by Fleiss, 18 ICCs greater than 0.75 were interpreted as excellent, values between 0.40 and 0.75 were interpreted as fair-to-good, and values less than 0.40 were interpreted as poor.
Results
Internal consistency reliabilities of the 6 GPMAS subscales (n = 26) were acceptable to good. Table 1 depicts Cronbach alpha coefficients for each of the subscales as well as the ICCs for the 6 GPMAS subscales. Based on these data, the test-retest reliabilities of the 6 subscales were excellent. To examine the concurrent validity of the therapists' self-reported ratings of the elements emphasized in therapy sessions, we determined the convergence of these measures with patient reporting of the emphasized elements. The ICC between the patient-and therapist-rated sessions (n = 26) was 0.91 (excellent). The mean levels of emphasis drawn from all therapist-rated sessions (n = 247) for the different subscales across the 3 phases of year-long treatment were calculated ( Figure 2 ). As expected, there was a trend toward greater emphasis on assessment procedure interventions during the early phases of treatment relative to middle and late sessions, while more emphasis was placed on specific interventions relating to termination during the later phases of treatment, compared with early and middle sessions. Mean levels of emphasis were significantly different between classes of interventions (Figure 3 ). For example, the means of GPM and GPM essential interventions were significantly greater than the mean of the DBT items across all time points (GPM and GPM essential interventions at early phase of treatment: F = 11.26, df = 2,147, P < 0.01; GPM and GPM essential interventions at middle phase of treatment: F = 10.53, df = 2,147, P < 0.01; and GPM and GPM essential interventions at late phase of treatment: F = 10.33, df = 2,147, P < 0.01). There were no significant differences between the means of GPM and GPM essential interventions at any phase of treatment.
The average number of prescribed psychotropic medications that patients received during 1 year of therapy from their therapists or the psychiatrists overseeing the pharmacologic management for patients seen by nonphysician therapists was 2.33 (SD 2.08). Thirty-six percent of patients were taking no psychotropic medications, 16% were taking 1 medication, 20% were taking 2, 16% were taking 3, 4% were taking 4, 2% were taking 5, and 6% were taking 6 or more medications. Among the different classes of medication, 38% of patients were prescribed antidepressants, 34% were prescribed antipsychotics, 18% were prescribed mood stabilizers, 18% were prescribed sedative-hypnotics, and 8% were prescribed other psychotropic medications, which is consistent with the APA's guideline that SSRIs and related antidepressants be used as first-line pharmacologic treatment for mood lability and impulsivity in BPD.
Discussion
Our report describes the development and implementation of GPM, a psychosocial intervention combined with symptomtargeted medication management derived from the APA's Practice Guideline for the Treatment of Patients with BPD. 8 Although the efficacy of GPM is currently being evaluated in comparison with DBT in an RCT, statistically significant improvement in self-harm frequency; emergency department visits; medical risk of self-harm; and measures of global severity, anger, and interpersonal functioning were demonstrated after 4 months of GPM, compared with baseline. 19 Therefore, this study of GPM is warranted, as the approach is based on an expert consensus and initial evidence for its efficacy. Several findings emerged from this study. First, we were able to demonstrate that the GPMAS displays good-to-excellent reliability and validity. Second, we established that therapists delivering GPM were adherent to this model. Third, we have confirmed that the prescribing patterns of the physician therapists participating in GPM largely conformed to the pharmacologic algorithms outlined in the APA's guideline.
For the first finding, our confidence in the strong psychometric properties of the GPMAS is bolstered by the fact that several measures were used to assess overall levels of reliability and validity. The high internal consistency and test-retest reliability of the GPMAS compare favourably with reliability levels documented in other studies looking at therapist adherence to manual-driven therapy and rating scales. [20] [21] [22] [23] [24] Zanarini et al 25 found that the Revised Diagnostic Interview for Borderlines displayed good-to-excellent test-retest reliability when subjects with BPD were interviewed by different raters 7 to 10 days apart. The authors highlighted the significance of this finding, given the inherent difficulties in obtaining consistent and reliable information from unpredictable subjects. We report similar levels of agreement between the 2 groups (for example, therapists and subjects) who evaluated the GPM therapists' treatment integrity and would argue that this consensus provides direct evidence for the validity of the GPMAS.
One of the principal objectives of this investigation was to establish whether therapists delivering GPM were adherent to the interventions circumscribed by this model. The corollary to this objective was to determine whether GPM therapists were avoiding the use of DBT or prohibited interventions. Although some therapists maintain that the techniques assessed in psychotherapy studies are not representative of those employed in clinical practice, low adherence to manualized interventions renders interpretation of study results extremely difficult. 26 In this investigation, the amount of emphasis accorded to specific GPM interventions was used as a proxy for levels of therapist adherence. As our data revealed that essential variables were more often highly or moderately emphasized than prohibited variables across all time points and that both essential and GPM variables received significantly higher levels of emphasis relative to DBT variables at all phases of treatment, we can conclude with reasonable certainty that the therapists adhered closely to the GPM protocol. Stated somewhat differently, we confirmed that GPM therapists were not providing DBT. This latter point is relevant because research has demonstrated that lack of adherence to a specific therapeutic modality does not necessarily translate into poor outcomes. 27 However, because we were able to demonstrate that the therapists in our study used behavioural techniques very infrequently, these findings should provide the foundation for future studies examining outcomes related to GPM treatment.
Our finding that subjects in this study were taking, on average, greater than 2 prescription psychotropic medications corroborates work carried out by other research groups. 3 As outlined in the APA's guideline, SSRIs are the preferred choice for targeting symptoms of affective dysregulation or impulsive-behavioural dyscontrol, while low-dose neuroleptics should be considered first-line treatment for amelioration of cognitive-perceptual symptoms. In our sample of patients, antidepressants, including SSRIs, were the most commonly prescribed psychotropic medications followed by neuroleptics. This result parallels that obtained by Oldham et al, 28 who reported that the most commonly used psychotropic medication among their sample of subjects participating in the Collaborative Longitudinal Personality Disorders Study was also SSRIs. However, as use of SSRIs was not predicted by the presence of subjects endorsing either prominent affective dysregulation or impulsive-behavioural dyscontrol, this team of investigators reasoned that high rates 
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of comorbid major depression in this population could have mediated the increased number of antidepressant prescriptions. While this caveat is certainly important to bear in mind, our investigation differed from the previous in that the APA's guideline was made available to the GPM therapists prior to the commencement of the study. In fact, clinicians were encouraged to adhere to the medication algorithms elucidated in the APA's guideline unless patient preferences or extenuating circumstances dictated otherwise. Thus these results can be interpreted as another indicator of the therapists' adherence to the GPM protocol.
Several limitations of the present investigation must be noted.
One limitation was that we did not assess the competence level of GPM therapists. Some researchers have argued that measuring competence levels among therapists is necessary as adherence to techniques provides no guarantee that the treatment was delivered appropriately. 21 However, other investigators have documented moderate levels of covariance between adherence and competence in dynamic therapy process studies. 29 Nevertheless, as the purpose of our investigation was to validate GPM as an appropriate comparison group with DBT by means of confirming acceptable treatment integrity among therapists to the former condition, we were not primarily concerned with assessing the clinicians' level of competence. Instead, our objective was to create a condition where BPD patients could expect to receive care reflective of typical outpatient settings but without the benefit of DBT. A second limitation of the study was that the therapy sessions studied comprised a convenience sample. In the absence of a randomly selected sample of tapes, it is difficult if not impossible to comment on the generalizability of the results. Lacking a systematic measure of convergence between therapistand independently rated sessions was another limitation. Two of the investigators listened to a subset of taped sessions and rated the first third of the session to ensure that DBT items were not emphasized. Among the 23 sessions sampled, there was fair-to-good concordance between the observer-rated level of emphasis and the overall self-reported level of emphasis in that GPM interventions were highly emphasized in both ratings, while DBT items were rarely employed. However, further development of the GPMAS should systematically evaluate self-report GPMAS against observer ratings of psychotherapy sessions. Finally, the therapists participating in this study were not blind to the fact that they were prohibited from using DBT techniques. In fact, 1 or 2 of the therapists who were identified as using prohibited interventions during the early phase of treatment were given feedback to avoid these strategies. Therefore, it is possible that the adherence levels we reported were an overestimation of what might have been observed in a more naturalistic study design.
In conclusion, we demonstrated in this investigation that the GPMAS displays strong psychometric properties and that the therapists sampled adhered closely to GPM interventions and corresponding medication algorithms. The GPMAS is potentially a useful tool in future research to gauge the implementation of the APA guideline-based interventions for BPD such as GPM. 
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Résumé : Démonstration de l'observance des guides de traitement des patients souffrant du trouble de la personnalité limite
Objectif : Décrire l'élaboration et la mise en oeuvre de la gestion psychiatrique générale (GPG), une approche de psychothérapie dynamique éclairée, de prise en charge des cas ainsi que d'interventions pharmacologiques ciblées sur les symptômes pour le traitement du trouble de la personnalité limite (TPL). Cette approche est tirée des guides de pratique de l'American Psychiatric Association (APA) pour le traitement du TPL.
Méthode : L'observance clinique de la GPG a été évaluée à l'aide de l'échelle d'observance de la gestion psychiatrique générale (EOGPG), qui mesurait le degré d'importance accordé aux outils et aux stratégies thérapeutiques durant les séances de thérapie individuelles. Les questionnaires d'EOGPG ont été remplis par 9 différents thérapeutes, à toutes les 6 semaines pendant un an pour 50 patients.
Résultats : L'EOGPG a révélé une excellente cohésion interne et une fiabilité test-retest de bonne à excellente. La convergence entre les séances cotées par le patient et par le thérapeute était excellente. Les niveaux moyens du degré d'importance étaient significativement plus élevés pour les interventions de GPG que pour celles proscrites, à tous les points chronologiques. Le nombre moyen de médicaments psychotropes prescrits était de 2,3; les antidépresseurs étaient la classe de médicaments les plus souvent prescrits, suivis des neuroleptiques.
Conclusions : D'après ces résultats, nous concluons que les cliniciens ont observé le protocole indiqué et que l'EOGPG est une mesure valable pour démontrer l'observance des thérapies basées sur les guides de pratique de l'APA.
